nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetohydroxamic Acid—MMP12—Collagen degradation—CTSD—breast cancer	0.011	0.0323	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Matrix Metalloproteinases—MMP3—breast cancer	0.00953	0.0279	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—ZEB2—breast cancer	0.00925	0.0271	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Collagen degradation—ADAM10—breast cancer	0.00872	0.0255	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—ADAMTS1—breast cancer	0.0084	0.0246	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAUR—breast cancer	0.00814	0.0239	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLG—breast cancer	0.00796	0.0233	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Collagen degradation—MMP3—breast cancer	0.00788	0.0231	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—ZEB1—breast cancer	0.00767	0.0225	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Matrix Metalloproteinases—MMP1—breast cancer	0.00762	0.0223	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—MIF—breast cancer	0.00738	0.0216	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—breast cancer	0.00728	0.0213	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—NTN4—breast cancer	0.00701	0.0205	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—HGF—breast cancer	0.00684	0.02	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Collagen degradation—MMP1—breast cancer	0.0063	0.0185	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Matrix Metalloproteinases—MMP2—breast cancer	0.00589	0.0173	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—COL7A1—breast cancer	0.00581	0.017	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—breast cancer	0.00571	0.0167	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—CTSD—breast cancer	0.00558	0.0163	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—EFEMP1—breast cancer	0.00554	0.0162	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FN1—breast cancer	0.00531	0.0156	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—FOXP3—breast cancer	0.00512	0.015	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Collagen degradation—MMP2—breast cancer	0.00488	0.0143	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CXCL2—breast cancer	0.00465	0.0136	CbGpPWpGaD
Acetohydroxamic Acid—Hydroxyurea—CYP2D6—breast cancer	0.00464	1	CrCbGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—LOXL2—breast cancer	0.00452	0.0132	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Matrix Metalloproteinases—MMP9—breast cancer	0.00443	0.013	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—breast cancer	0.00442	0.0129	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—ADAM10—breast cancer	0.00441	0.0129	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—PLG—breast cancer	0.00436	0.0128	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—THBS1—breast cancer	0.00401	0.0117	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—MMP3—breast cancer	0.00399	0.0117	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Collagen degradation—MMP9—breast cancer	0.00367	0.0107	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—EGR1—breast cancer	0.00363	0.0106	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—ADAMTS1—breast cancer	0.00352	0.0103	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—SPP1—breast cancer	0.00349	0.0102	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Matrix Metalloproteinases—TNF—breast cancer	0.00341	0.00999	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—breast cancer	0.00338	0.00991	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—MMP1—breast cancer	0.00319	0.00935	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SRC—breast cancer	0.00312	0.00914	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—TGFBR2—breast cancer	0.00298	0.00873	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—E2F1—breast cancer	0.0029	0.00849	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—SMAD4—breast cancer	0.00282	0.00826	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—breast cancer	0.00279	0.00817	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—breast cancer	0.00273	0.00801	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—BMP4—breast cancer	0.0026	0.0076	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—CDH1—breast cancer	0.00256	0.00751	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CDK2—breast cancer	0.0025	0.00732	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—MMP2—breast cancer	0.00247	0.00723	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—LEP—breast cancer	0.00246	0.00722	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—TERT—breast cancer	0.00241	0.00707	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—BMP2—breast cancer	0.00241	0.00707	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CDK4—breast cancer	0.00236	0.00692	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—CTSD—breast cancer	0.00234	0.00685	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MMP1—breast cancer	0.00233	0.00682	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—TGFB2—breast cancer	0.00231	0.00678	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—THBS1—breast cancer	0.0023	0.00674	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—NOS2—breast cancer	0.0023	0.00673	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CAV1—breast cancer	0.00223	0.00654	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MET—breast cancer	0.00216	0.00633	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—FN1—breast cancer	0.00212	0.00622	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—FOS—breast cancer	0.00212	0.00621	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—RB1—breast cancer	0.00205	0.00602	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—CASP3—breast cancer	0.00196	0.00575	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—FOS—breast cancer	0.00194	0.00568	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—MMP9—breast cancer	0.00186	0.00544	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—ADAM10—breast cancer	0.00185	0.00542	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—PLG—breast cancer	0.00183	0.00536	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—IFNG—breast cancer	0.00176	0.00516	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—PDGFA—breast cancer	0.00174	0.00509	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—PTGS2—breast cancer	0.00169	0.00495	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—MMP3—breast cancer	0.00167	0.0049	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CXCL8—breast cancer	0.00164	0.0048	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CDKN1B—breast cancer	0.0016	0.00468	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—RAF1—breast cancer	0.0016	0.00467	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—IL1B—breast cancer	0.00157	0.0046	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CASP3—breast cancer	0.00157	0.00459	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—IL2—breast cancer	0.00156	0.00458	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CCND1—breast cancer	0.00153	0.00447	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—MMP9—breast cancer	0.00148	0.00434	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—SPP1—breast cancer	0.00146	0.00428	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CCND1—breast cancer	0.00139	0.00409	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—JUN—breast cancer	0.00139	0.00408	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CDKN1A—breast cancer	0.00135	0.00395	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—MMP1—breast cancer	0.00134	0.00392	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MAPK8—breast cancer	0.00132	0.00386	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—KDR—breast cancer	0.00127	0.00371	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—MAPK3—breast cancer	0.00126	0.00369	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—SRC—breast cancer	0.00125	0.00366	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—MYC—breast cancer	0.00122	0.00358	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—TGFB1—breast cancer	0.00122	0.00358	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—FN1—breast cancer	0.00122	0.00357	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—EGFR—breast cancer	0.0012	0.00351	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—TNF—breast cancer	0.00114	0.00334	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MYC—breast cancer	0.00112	0.00328	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—TGFB1—breast cancer	0.00112	0.00327	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—CDH1—breast cancer	0.00107	0.00315	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—MMP2—breast cancer	0.00103	0.00303	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—SERPINE1—breast cancer	0.00102	0.00297	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—TP53—breast cancer	0.001	0.00294	CbGpPWpGaD
Acetohydroxamic Acid—Dermatitis—Raloxifene—breast cancer	0.000983	0.0015	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Idarubicin—breast cancer	0.000983	0.0015	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Tamoxifen—breast cancer	0.000978	0.0015	CcSEcCtD
Acetohydroxamic Acid—Headache—Raloxifene—breast cancer	0.000977	0.00149	CcSEcCtD
Acetohydroxamic Acid—Headache—Idarubicin—breast cancer	0.000977	0.00149	CcSEcCtD
Acetohydroxamic Acid—Nausea—Letrozole—breast cancer	0.000976	0.00149	CcSEcCtD
Acetohydroxamic Acid—Nausea—Anastrozole—breast cancer	0.000976	0.00149	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Tamoxifen—breast cancer	0.000971	0.00148	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Tamoxifen—breast cancer	0.00097	0.00148	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Gemcitabine—breast cancer	0.000961	0.00147	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Melphalan—breast cancer	0.000957	0.00146	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Thiotepa—breast cancer	0.000955	0.00146	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Vinblastine—breast cancer	0.000954	0.00146	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Melphalan—breast cancer	0.000951	0.00145	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Melphalan—breast cancer	0.00095	0.00145	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Fluorouracil—breast cancer	0.000945	0.00145	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Goserelin—breast cancer	0.000934	0.00143	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Methotrexate—breast cancer	0.000929	0.00142	CcSEcCtD
Acetohydroxamic Acid—Nausea—Idarubicin—breast cancer	0.000927	0.00142	CcSEcCtD
Acetohydroxamic Acid—Nausea—Raloxifene—breast cancer	0.000927	0.00142	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Goserelin—breast cancer	0.000926	0.00142	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—IL6—breast cancer	0.00092	0.00269	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—TP53—breast cancer	0.000919	0.00269	CbGpPWpGaD
Acetohydroxamic Acid—Anorexia—Vinorelbine—breast cancer	0.000917	0.0014	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Chlorambucil—breast cancer	0.000907	0.00139	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Mitoxantrone—breast cancer	0.000902	0.00138	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Irinotecan—breast cancer	0.000902	0.00138	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Irinotecan—breast cancer	0.000899	0.00137	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Mitoxantrone—breast cancer	0.000899	0.00137	CcSEcCtD
Acetohydroxamic Acid—Abdominal discomfort—Capecitabine—breast cancer	0.000895	0.00137	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Goserelin—breast cancer	0.000885	0.00135	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Gemcitabine—breast cancer	0.000879	0.00134	CcSEcCtD
Acetohydroxamic Acid—Malaise—Mitoxantrone—breast cancer	0.000877	0.00134	CcSEcCtD
Acetohydroxamic Acid—Malaise—Irinotecan—breast cancer	0.000877	0.00134	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Thiotepa—breast cancer	0.000876	0.00134	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Gemcitabine—breast cancer	0.000875	0.00134	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Epirubicin—breast cancer	0.00087	0.00133	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Fluorouracil—breast cancer	0.000861	0.00132	CcSEcCtD
Acetohydroxamic Acid—Malaise—Gemcitabine—breast cancer	0.000854	0.00131	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Docetaxel—breast cancer	0.000845	0.00129	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Vinorelbine—breast cancer	0.000836	0.00128	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Vinblastine—breast cancer	0.000831	0.00127	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Vinorelbine—breast cancer	0.000831	0.00127	CcSEcCtD
Acetohydroxamic Acid—Depression—Capecitabine—breast cancer	0.00083	0.00127	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Vinorelbine—breast cancer	0.00083	0.00127	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Mitoxantrone—breast cancer	0.000825	0.00126	CcSEcCtD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—CASP3—breast cancer	0.000823	0.00241	CbGpPWpGaD
Acetohydroxamic Acid—Lethargy—Methotrexate—breast cancer	0.000821	0.00126	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Capecitabine—breast cancer	0.000819	0.00125	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Mitoxantrone—breast cancer	0.000818	0.00125	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Irinotecan—breast cancer	0.000818	0.00125	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Tamoxifen—breast cancer	0.000807	0.00123	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Paclitaxel—breast cancer	0.000805	0.00123	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Doxorubicin—breast cancer	0.000805	0.00123	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Chlorambucil—breast cancer	0.000803	0.00123	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Thiotepa—breast cancer	0.000799	0.00122	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Gemcitabine—breast cancer	0.000797	0.00122	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Thiotepa—breast cancer	0.000793	0.00121	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Vinorelbine—breast cancer	0.000793	0.00121	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Thiotepa—breast cancer	0.000792	0.00121	CcSEcCtD
Acetohydroxamic Acid—Renal impairment—Epirubicin—breast cancer	0.000791	0.00121	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Melphalan—breast cancer	0.00079	0.00121	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Fluorouracil—breast cancer	0.000783	0.0012	CcSEcCtD
Acetohydroxamic Acid—Tension—Paclitaxel—breast cancer	0.000778	0.00119	CcSEcCtD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—MMP9—breast cancer	0.000778	0.00228	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—AKT1—breast cancer	0.000776	0.00227	CbGpPWpGaD
Acetohydroxamic Acid—Asthenia—Goserelin—breast cancer	0.000771	0.00118	CcSEcCtD
Acetohydroxamic Acid—Nervousness—Paclitaxel—breast cancer	0.00077	0.00118	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Epirubicin—breast cancer	0.000768	0.00117	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Thiotepa—breast cancer	0.000757	0.00116	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Irinotecan—breast cancer	0.000756	0.00116	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Mitoxantrone—breast cancer	0.000756	0.00116	CcSEcCtD
Acetohydroxamic Acid—Nausea—Chlorambucil—breast cancer	0.00075	0.00115	CcSEcCtD
Acetohydroxamic Acid—Tremor—Paclitaxel—breast cancer	0.000743	0.00114	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Gemcitabine—breast cancer	0.000737	0.00113	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Vinblastine—breast cancer	0.000736	0.00113	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Paclitaxel—breast cancer	0.000736	0.00113	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Paclitaxel—breast cancer	0.000733	0.00112	CcSEcCtD
Acetohydroxamic Acid—Renal impairment—Doxorubicin—breast cancer	0.000732	0.00112	CcSEcCtD
Acetohydroxamic Acid—Headache—Vinblastine—breast cancer	0.000725	0.00111	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Fluorouracil—breast cancer	0.000724	0.00111	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Tamoxifen—breast cancer	0.000715	0.00109	CcSEcCtD
Acetohydroxamic Acid—Malaise—Paclitaxel—breast cancer	0.000715	0.00109	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Doxorubicin—breast cancer	0.000711	0.00109	CcSEcCtD
Acetohydroxamic Acid—Rash—Tamoxifen—breast cancer	0.000709	0.00108	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Tamoxifen—breast cancer	0.000709	0.00108	CcSEcCtD
Acetohydroxamic Acid—Headache—Tamoxifen—breast cancer	0.000705	0.00108	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Paclitaxel—breast cancer	0.000701	0.00107	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Melphalan—breast cancer	0.0007	0.00107	CcSEcCtD
Acetohydroxamic Acid—Rash—Melphalan—breast cancer	0.000694	0.00106	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Melphalan—breast cancer	0.000694	0.00106	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Vinorelbine—breast cancer	0.00069	0.00106	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Mitoxantrone—breast cancer	0.00069	0.00105	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Irinotecan—breast cancer	0.00069	0.00105	CcSEcCtD
Acetohydroxamic Acid—Nausea—Vinblastine—breast cancer	0.000688	0.00105	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Irinotecan—breast cancer	0.000685	0.00105	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Irinotecan—breast cancer	0.000684	0.00105	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Mitoxantrone—breast cancer	0.000684	0.00105	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Goserelin—breast cancer	0.000683	0.00104	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Docetaxel—breast cancer	0.000682	0.00104	CcSEcCtD
Acetohydroxamic Acid—Rash—Goserelin—breast cancer	0.000677	0.00104	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Goserelin—breast cancer	0.000677	0.00103	CcSEcCtD
Acetohydroxamic Acid—Headache—Goserelin—breast cancer	0.000673	0.00103	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Paclitaxel—breast cancer	0.000673	0.00103	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Gemcitabine—breast cancer	0.000672	0.00103	CcSEcCtD
Acetohydroxamic Acid—Nausea—Tamoxifen—breast cancer	0.000668	0.00102	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000667	0.00102	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Paclitaxel—breast cancer	0.000667	0.00102	CcSEcCtD
Acetohydroxamic Acid—Abdominal discomfort—Methotrexate—breast cancer	0.000667	0.00102	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Gemcitabine—breast cancer	0.000666	0.00102	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Fluorouracil—breast cancer	0.000661	0.00101	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Capecitabine—breast cancer	0.000661	0.00101	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Thiotepa—breast cancer	0.000659	0.00101	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000656	0.001	CcSEcCtD
Acetohydroxamic Acid—Nausea—Melphalan—breast cancer	0.000654	0.001	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Irinotecan—breast cancer	0.000654	0.001	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Mitoxantrone—breast cancer	0.000654	0.001	CcSEcCtD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—TGFB1—breast cancer	0.000641	0.00188	CbGpPWpGaD
Acetohydroxamic Acid—Nausea—Goserelin—breast cancer	0.000638	0.000976	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Gemcitabine—breast cancer	0.000637	0.000974	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Fluorouracil—breast cancer	0.000626	0.000958	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Docetaxel—breast cancer	0.000621	0.00095	CcSEcCtD
Acetohydroxamic Acid—Depression—Methotrexate—breast cancer	0.000618	0.000945	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Paclitaxel—breast cancer	0.000617	0.000943	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Vinorelbine—breast cancer	0.000612	0.000935	CcSEcCtD
Acetohydroxamic Acid—Tremor—Capecitabine—breast cancer	0.00061	0.000932	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Methotrexate—breast cancer	0.000609	0.000932	CcSEcCtD
Acetohydroxamic Acid—Rash—Vinorelbine—breast cancer	0.000607	0.000928	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Vinorelbine—breast cancer	0.000606	0.000927	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Capecitabine—breast cancer	0.000604	0.000923	CcSEcCtD
Acetohydroxamic Acid—Headache—Vinorelbine—breast cancer	0.000603	0.000922	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Capecitabine—breast cancer	0.000601	0.00092	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Docetaxel—breast cancer	0.000594	0.000908	CcSEcCtD
Acetohydroxamic Acid—Malaise—Capecitabine—breast cancer	0.000587	0.000897	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Thiotepa—breast cancer	0.000584	0.000893	CcSEcCtD
Acetohydroxamic Acid—Rash—Thiotepa—breast cancer	0.000579	0.000886	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Thiotepa—breast cancer	0.000579	0.000885	CcSEcCtD
Acetohydroxamic Acid—Headache—Thiotepa—breast cancer	0.000576	0.00088	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Capecitabine—breast cancer	0.000575	0.000879	CcSEcCtD
Acetohydroxamic Acid—Nausea—Vinorelbine—breast cancer	0.000572	0.000874	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Epirubicin—breast cancer	0.00057	0.000872	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Mitoxantrone—breast cancer	0.000569	0.000871	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Irinotecan—breast cancer	0.000569	0.000871	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Paclitaxel—breast cancer	0.000563	0.00086	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000559	0.000854	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Paclitaxel—breast cancer	0.000558	0.000853	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Gemcitabine—breast cancer	0.000555	0.000848	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Capecitabine—breast cancer	0.000552	0.000844	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Capecitabine—breast cancer	0.000547	0.000837	CcSEcCtD
Acetohydroxamic Acid—Nausea—Thiotepa—breast cancer	0.000546	0.000835	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Paclitaxel—breast cancer	0.000533	0.000815	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Doxorubicin—breast cancer	0.000528	0.000807	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Docetaxel—breast cancer	0.000523	0.0008	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Capecitabine—breast cancer	0.000506	0.000774	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Mitoxantrone—breast cancer	0.000505	0.000771	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Irinotecan—breast cancer	0.000505	0.000771	CcSEcCtD
Acetohydroxamic Acid—Rash—Mitoxantrone—breast cancer	0.0005	0.000765	CcSEcCtD
Acetohydroxamic Acid—Rash—Irinotecan—breast cancer	0.0005	0.000765	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Irinotecan—breast cancer	0.0005	0.000764	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Mitoxantrone—breast cancer	0.0005	0.000764	CcSEcCtD
Acetohydroxamic Acid—Headache—Mitoxantrone—breast cancer	0.000497	0.00076	CcSEcCtD
Acetohydroxamic Acid—Headache—Irinotecan—breast cancer	0.000497	0.00076	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Methotrexate—breast cancer	0.000492	0.000752	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Gemcitabine—breast cancer	0.000491	0.000752	CcSEcCtD
Acetohydroxamic Acid—Rash—Gemcitabine—breast cancer	0.000487	0.000745	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Gemcitabine—breast cancer	0.000487	0.000745	CcSEcCtD
Acetohydroxamic Acid—Headache—Gemcitabine—breast cancer	0.000484	0.00074	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Fluorouracil—breast cancer	0.000483	0.000739	CcSEcCtD
Acetohydroxamic Acid—Rash—Fluorouracil—breast cancer	0.000479	0.000733	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Fluorouracil—breast cancer	0.000479	0.000732	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Docetaxel—breast cancer	0.000477	0.000729	CcSEcCtD
Acetohydroxamic Acid—Headache—Fluorouracil—breast cancer	0.000476	0.000728	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Docetaxel—breast cancer	0.000474	0.000724	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Docetaxel—breast cancer	0.000473	0.000723	CcSEcCtD
Acetohydroxamic Acid—Nausea—Mitoxantrone—breast cancer	0.000471	0.000721	CcSEcCtD
Acetohydroxamic Acid—Nausea—Irinotecan—breast cancer	0.000471	0.000721	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Paclitaxel—breast cancer	0.000464	0.00071	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Capecitabine—breast cancer	0.000462	0.000706	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Epirubicin—breast cancer	0.00046	0.000704	CcSEcCtD
Acetohydroxamic Acid—Nausea—Gemcitabine—breast cancer	0.000459	0.000702	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Capecitabine—breast cancer	0.000459	0.000701	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Capecitabine—breast cancer	0.000458	0.0007	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Docetaxel—breast cancer	0.000452	0.000691	CcSEcCtD
Acetohydroxamic Acid—Nausea—Fluorouracil—breast cancer	0.000451	0.00069	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Methotrexate—breast cancer	0.000449	0.000687	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Methotrexate—breast cancer	0.000448	0.000685	CcSEcCtD
Acetohydroxamic Acid—Tension—Epirubicin—breast cancer	0.000445	0.00068	CcSEcCtD
Acetohydroxamic Acid—Nervousness—Epirubicin—breast cancer	0.00044	0.000673	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Capecitabine—breast cancer	0.000438	0.000669	CcSEcCtD
Acetohydroxamic Acid—Malaise—Methotrexate—breast cancer	0.000437	0.000668	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Doxorubicin—breast cancer	0.000426	0.000651	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Epirubicin—breast cancer	0.000421	0.000643	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Epirubicin—breast cancer	0.000419	0.000641	CcSEcCtD
Acetohydroxamic Acid—Tension—Doxorubicin—breast cancer	0.000412	0.000629	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Paclitaxel—breast cancer	0.000411	0.000629	CcSEcCtD
Acetohydroxamic Acid—Malaise—Epirubicin—breast cancer	0.000409	0.000625	CcSEcCtD
Acetohydroxamic Acid—Rash—Paclitaxel—breast cancer	0.000408	0.000624	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Paclitaxel—breast cancer	0.000408	0.000623	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Methotrexate—breast cancer	0.000407	0.000623	CcSEcCtD
Acetohydroxamic Acid—Nervousness—Doxorubicin—breast cancer	0.000407	0.000623	CcSEcCtD
Acetohydroxamic Acid—Headache—Paclitaxel—breast cancer	0.000405	0.00062	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Epirubicin—breast cancer	0.000401	0.000613	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Docetaxel—breast cancer	0.000394	0.000602	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Doxorubicin—breast cancer	0.000389	0.000595	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Doxorubicin—breast cancer	0.000388	0.000593	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Epirubicin—breast cancer	0.000385	0.000588	CcSEcCtD
Acetohydroxamic Acid—Nausea—Paclitaxel—breast cancer	0.000384	0.000588	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Epirubicin—breast cancer	0.000381	0.000583	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Capecitabine—breast cancer	0.000381	0.000583	CcSEcCtD
Acetohydroxamic Acid—Malaise—Doxorubicin—breast cancer	0.000378	0.000578	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Methotrexate—breast cancer	0.000377	0.000576	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Doxorubicin—breast cancer	0.000371	0.000567	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Doxorubicin—breast cancer	0.000356	0.000544	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Doxorubicin—breast cancer	0.000353	0.00054	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Epirubicin—breast cancer	0.000353	0.000539	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Docetaxel—breast cancer	0.000349	0.000533	CcSEcCtD
Acetohydroxamic Acid—Rash—Docetaxel—breast cancer	0.000346	0.000529	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Docetaxel—breast cancer	0.000346	0.000528	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Methotrexate—breast cancer	0.000344	0.000526	CcSEcCtD
Acetohydroxamic Acid—Headache—Docetaxel—breast cancer	0.000344	0.000525	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Methotrexate—breast cancer	0.000341	0.000522	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Methotrexate—breast cancer	0.000341	0.000521	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Capecitabine—breast cancer	0.000338	0.000516	CcSEcCtD
Acetohydroxamic Acid—Rash—Capecitabine—breast cancer	0.000335	0.000512	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Capecitabine—breast cancer	0.000335	0.000512	CcSEcCtD
Acetohydroxamic Acid—Headache—Capecitabine—breast cancer	0.000333	0.000509	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Doxorubicin—breast cancer	0.000326	0.000499	CcSEcCtD
Acetohydroxamic Acid—Nausea—Docetaxel—breast cancer	0.000326	0.000498	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Methotrexate—breast cancer	0.000326	0.000498	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Epirubicin—breast cancer	0.000322	0.000492	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Epirubicin—breast cancer	0.000319	0.000488	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Epirubicin—breast cancer	0.000319	0.000488	CcSEcCtD
Acetohydroxamic Acid—Nausea—Capecitabine—breast cancer	0.000315	0.000482	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Epirubicin—breast cancer	0.000305	0.000466	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Doxorubicin—breast cancer	0.000298	0.000455	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000296	0.000452	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Doxorubicin—breast cancer	0.000295	0.000451	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Methotrexate—breast cancer	0.000284	0.000434	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Doxorubicin—breast cancer	0.000282	0.000431	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Epirubicin—breast cancer	0.000265	0.000406	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Methotrexate—breast cancer	0.000251	0.000384	CcSEcCtD
Acetohydroxamic Acid—Rash—Methotrexate—breast cancer	0.000249	0.000381	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Methotrexate—breast cancer	0.000249	0.000381	CcSEcCtD
Acetohydroxamic Acid—Headache—Methotrexate—breast cancer	0.000248	0.000379	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Doxorubicin—breast cancer	0.000246	0.000376	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Epirubicin—breast cancer	0.000235	0.00036	CcSEcCtD
Acetohydroxamic Acid—Nausea—Methotrexate—breast cancer	0.000235	0.000359	CcSEcCtD
Acetohydroxamic Acid—Rash—Epirubicin—breast cancer	0.000233	0.000357	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Epirubicin—breast cancer	0.000233	0.000356	CcSEcCtD
Acetohydroxamic Acid—Headache—Epirubicin—breast cancer	0.000232	0.000354	CcSEcCtD
Acetohydroxamic Acid—Nausea—Epirubicin—breast cancer	0.00022	0.000336	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Doxorubicin—breast cancer	0.000218	0.000333	CcSEcCtD
Acetohydroxamic Acid—Rash—Doxorubicin—breast cancer	0.000216	0.00033	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Doxorubicin—breast cancer	0.000216	0.00033	CcSEcCtD
Acetohydroxamic Acid—Headache—Doxorubicin—breast cancer	0.000214	0.000328	CcSEcCtD
Acetohydroxamic Acid—Nausea—Doxorubicin—breast cancer	0.000203	0.000311	CcSEcCtD
